UPDATE : Friday, May 25, 2018
상단여백
B. Braun Korea names Stephan Soyka as new general manager
Stephan Soyka German medical device firm B. Braun said Thursday that it n...
by Marian Chu  |  2018-04-19 13:34
라인
Hanmi unveils 3 drug candidates at US cancer conference
Visitors view Hanmi's research results on anti-cancer drug candidates at th...
by Lee Han-soo  |  2018-04-18 16:49
라인
AstraZeneca up, Novartis down in Q1 outpatient prescriptions
AstraZeneca Korea’s outpatient prescription drug sales expanded by 7 billio...
by Nam Doo-hyun  |  2018-04-18 14:58
라인
Roche Korea gets expanded approval for breast cancer drug
Roche Korea said that its breast cancer therapy Perjeta got the Ministry of...
by Marian Chu  |  2018-04-18 13:13
라인
Exhibition showcases latest pharma products, trends
An international pharmaceutical exhibition opened at the Korea Internationa...
by Lee Hye-seon  |  2018-04-17 16:14
라인
Genexine unveils trial results for immunotherapeutic agent
Genexine and NeoImmuneTech said Tuesday that they have presented animal tri...
by Lee Han-soo  |  2018-04-17 15:13
라인
How are Korean drugmakers performing in China?
The pharmaceutical industry is paying attention to how Korean drugmakers ar...
by So Jae-hyeon  |  2018-04-17 15:12
라인
Handok to sell Astellas’ diabetes therapy
Handok said Monday that it signed a sales contract with Astellas Korea to s...
by Marian Chu  |  2018-04-17 13:52
라인
GemVax & KAEL gets positive P2 data on GV1001 for prostate hyperplasia
GemVax & KAEL said that it proved clinical efficacy of GV1001 on benign pro...
by Marian Chu  |  2018-04-16 16:50
라인
Humedix eyes global entry with skin-regenerating injection
Humedix, a Huons Global subsidiary, said it got approvals for both Revitalr...
by Marian Chu  |  2018-04-16 14:47
라인
Will anti-smoking drug Champix still be champion?
Korean drugmakers are expected to roll out generic copies of Pfizer’s smoki...
by So Jae-hyeon  |  2018-04-16 14:46
라인
Janssen Korea launches new psoriasis treatment
Janssen Korea said it has launched a follow-up drug of psoriasis treatment ...
by Lee Hye-seon  |  2018-04-16 11:48
라인
GE Healthcare Korea launches ₩2.5-bil. program to foster biotech
GE Healthcare Life Sciences Korea said Monday that it would provide 2.5 bil...
by Marian Chu  |  2018-04-16 11:45
라인
Roche Korea’s Alecensa gets approval as 1st line lung cancer therapy
Roche’s lung cancer therapy got the Ministry of Food and Drug Safety’s appr...
by Marian Chu  |  2018-04-13 16:46
라인
SillaJen reveals clinical results on Pexa-Vec in UK
SillaJen said it unveiled clinical results of REN022, a phase-2 study on Pe...
by So Jae-hyeon  |  2018-04-13 16:38
라인
Hanmi gives up on lung cancer drug Olita
Hanmi Pharmaceutical is expected to discontinue developing lung cancer trea...
by Lee Hye-seon  |  2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension
LG Chem said it has won approval from the Ministry of Food and Drug Safety ...
by Lee Hye-seon  |  2018-04-12 16:32
라인
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
The government has changed its approval for the efficacy and safety of Saxe...
by Nam Doo-hyun  |  2018-04-11 14:11
라인
YD Life Science preps diabetes complication therapy for global launch
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Marian Chu  |  2018-04-10 17:36
라인
JW Pharm discovers novel H4R antagonist for atopic dermatitis
JW Pharmaceuticals Tuesday said it discovered a novel orally available H4R ...
by Marian Chu  |  2018-04-10 17:36
여백
여백
여백
Back to Top